| Crude model | Adjusted modela |
---|
Difference | (95% CI) | P value | Difference | (95% CI) | P value |
---|
MTD, cm |
PASCS (n = 12b) | Reference | | | Reference | | |
PA (n = 41c) | −1.24 | (– 1.70 to −0.78) | < 0.001 | – 1.19 | (– 1.66 to − 0.72) | < 0.001 |
SCS (n = 12) | −0.04 | (– 0.58 to 0.57) | NS | – 0.01 | (– 0.55 to 0.54) | NS |
Serum potassium concentration, mEq/L |
PASCS (n = 12b) | Reference | | | Reference | | |
PA (n = 41c) | 0.23 | (−0.23 to 0.69) | NS | 0.24 | (−0.25 to 0.72) | NS |
SCS (n = 12) | 0.96 | (0.38 to 1.53) | < 0.005 | 0.97 | (0.38 to 1.54) | < 0.005 |
- aConsists of 65patients who had a unilateral adrenal tumor (41, 12, and 12 patients with PA, SCS, and PASCS, respectively). All the models were adjusted for age, sex, and BMI at the time of diagnosis
- bThe numbers of patients who remained after the exclusion of 2 patients who had bilateral tumors and who missed the maximum tumor diameter
- cThe numbers of patients who remained after the exclusion of the following patients who missed the maximum tumor diameter: 1 patient who had a unilateral adrenal tumor and 3 patients who had bilateral adrenal tumors
- PA primary aldosteronism, SCS subclinical Cushing’s syndrome, NS not significant, PASCS primary aldosteronism plus subclinical Cushing’s syndrome, CI confidence interval, MTD maximum tumor diameter